Skip to main content
Clinical Trials/NCT05357924
NCT05357924UnknownNot Applicable

Evaluating Ovarian Reserve After Conventional Laparoscopy Versus Robotic Surgery for Bilateral Endometrioma: a Randomized Controlled Trial.

Medical University of Vienna1 site in 1 country104 target enrollmentStarted: April 19, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
104
Locations
1
Primary Endpoint
Change in serum AMH (sAMH) from baseline to 6 months after the operation

Study Overview

Brief Summary

The aim of this study is to perform a randomized study investigating AMH recovery comparing robot-assisted laparoscopy and conventional laparoscopy in patients with bilateral ovarian endometrioma. It is hypothesized that in patients with endometriomas, a robot-assisted approach may provide improved instrument navigation resulting in more precise dissection and therefore removal of less healthy ovarian tissue compared to conventional laparoscopy. AMH is the most widely used parameter for predicting functional ovarian reserve. Postoperative AMH levels were associated with the number of follicles in specimens due to the removal of ovarian cortex during surgery . Furthermore, the reduction in AMH level after surgery is higher in bilateral endometrioma.

The investigators hypothesize, on the basis of Lee at al., 2020, that patients with bilateral endometrioma will have significantly higher AMH levels 6 months after robot-assisted laparoscopy than patients who were treated with conventional laparoscopy.

Therefore, the primary outcome is postoperative serum AMH level recovery in patients undergoing conventional laparoscopy versus robot-assisted laparoscopy.

Aims: The aim of this study is to investigate postoperative differences in ovarian reserve differing between robot-assisted laparoscopy compared to conventional laparoscopy in patients with bilaterial ovarian endometrioma by comparing serum AMH (sAMH) level recovery.

Study population: The study population will consist of women aged between 18 and 45 years who are referred to our gynecologic outpatient clinic due to bilateral endometrioma. Women with an indication for surgery can be included in this trial.

Methods: Laparoscopic-assisted resection of endometriosis will be performed using up to four 5-mm ports, including an umbilical port and additional ports as dictated by each individual surgery. The robotic-assisted resection of endometriosis will be performed using the da Vinci Surgical System Si (Intuitive Surgical) using up to five ports as needed. Superficial and deep endometriosis resection will be performed in the usual standard fashion. Histological confirmation of endometriosis will be performed. The primary outcome is postoperative serum AMH (sAMH) level recovery. This will be evaluated 6 months after surgery.

Detailed Description

Experimental Plan

Study design This trial is a prospective, randomized-controlled study investigating postoperative differences in ovarian reserve differing between robot-assisted laparoscopy compared to conventional laparoscopy in patients with bilaterial ovarian endometrioma by comparing serum AMH (sAMH) level recovery. Postoperative follow-up will take place after 6 months. All women referred to our department for endometrioma will undergo clinical examination by a senior surgeon experienced in endometriosis as well as ultrasound. All patients with bilateral endometrioma will be included. Complementary examinations, such as cystoscopy or renal sonography will be performed in women with suspected involvement of urinary tract.

In women with pregnancy intention and endometrioma, an exhaustive assessment of the disease will systematically be performed before deciding between primary surgery and primary assisted reproductive techniques.

Gynecological examination will be performed at each visit. Ovarian reserve will be evaluated using antral follicle count (AFC) via transvaginal sonography, anti-Mullerian hormone (AMH), follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels and ovarian volume.

Follicle number will be evaluated by pathologists in the histologic tissue sections.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Bilateral endometrioma
  • •Surgical endometriosis resection is planned
  • •sAMH > 1.0 ng/ml

Exclusion Criteria

  • •History of malignant diseases
  • •History of adnexal surgery
  • •Subject is unable or unwilling to participate
  • •Postmenopausal women

Arms & Interventions

robotic-assisted laparoscopy

Active Comparator

The robotic-assisted resection of endometriosis will be performed using the da Vinci Surgical System Si (Intuitive Surgical) using up to five ports as needed. An umbilical port was placed for the laparoscope (10/12 mm), a 5-mm port for the assistant, and two to three ports (5/8 mm) for the robotic arms.

Intervention: robotic-assisted laparoscopy (Procedure)

conventional laparoscopy

Active Comparator

Laparoscopic-assisted cystectomy of endometrioma will be performed using up to four 5-mm ports, including an umbilical port and additional ports as dictated by each individual surgery.

Intervention: Conventional laparoscopy (Procedure)

Outcomes

Primary Outcomes

Change in serum AMH (sAMH) from baseline to 6 months after the operation

Time Frame: 6 months after the operation

postoperative sAMH (6 months after the operation) compared to preoperative sAMH

Secondary Outcomes

  • Change in antral follicle count (AFC) from baseline to 6 months after the operation(6 months after the operation)
  • change in ovarian volume from baseline to 6 months after the operation(6 months after the operation)
  • change in follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from baseline to 6 months after the operation(6 months after the operation)
  • rate of intraoperative adverse events(1 day)
  • rate of postoperative adverse events(4 weeks)
  • operation time(1 day)
  • length of hospitalization (following the operation)(2 weeks)
  • blood loss(1 day)
  • laparotomic conversion rate(1 day)
  • follicle number in the histologic tissue sections(1 day)
  • change of the Endometriosis Health Profile (EHP) EHP-30 from baseline to 6 months after the operation(6 months after the operation)
  • 10-point Likert scale for cosmetic satisfaction(6 months after the operation)
  • Disease recurrence rate up to 12 months after surgery(12 months after the operation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christine Bekos

Principan Investigator

Medical University of Vienna

Study Sites (1)

Loading locations...

Similar Trials